Company Number: 14328295

Analysis Date: 2025-07-20 13:10 UTC

Financial Health Assessment for LAFRESH LTD as of 31 August 2024

---

1. Financial Health Score: B

Explanation:
LAFRESH LTD exhibits a generally healthy financial position with positive net current assets and net assets, reflecting a solid liquidity position and sound equity base for a young company. The company’s cash holdings are stable and exceed current liabilities by a comfortable margin, indicating good short-term financial stability. However, the absence of debtors and the relatively small scale of operations suggest limited business activity or early-stage development, which tempers the overall score.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Current Assets	5,345	Mainly cash; limited receivables indicating low credit sales or early-stage operations.
Cash	5,345	Healthy cash reserves relative to liabilities, indicating good liquidity ("healthy cash flow").
Debtors	0	No outstanding receivables; could imply prompt customer payments or low sales volume.
Current Liabilities	38	Very low short-term debts, indicating minimal financial obligations due soon ("no symptoms of distress").
Net Current Assets	5,307	Positive working capital, showing the company can cover short-term debts comfortably.
Net Assets / Equity	5,307	Positive net worth, indicating the business is solvent and has retained earnings.
Number of Employees	1	Small operational scale, consistent with a micro or small company profile.

---

3. Diagnosis

Underlying Financial Health:
LAFRESH LTD is displaying the financial signs of a young, stable but small-scale enterprise. The company’s liquidity is robust, with cash balances exceeding liabilities by a large margin, reflecting a "healthy cash flow" environment and no immediate risk of cash shortages. The lack of debtors may be a "symptom" of either limited customer credit or a business model focused on immediate payment. The minimal liabilities and positive equity confirm no immediate solvency concerns.

Business Activity Considerations:
The stagnant or unchanged debtor and asset figures between 2023 and 2024 suggest limited growth or a steady state of business activity. This could signal either a deliberate conservative approach or a need to stimulate business growth.

Accounting and Compliance:
The company complies with small entity accounting standards (FRS 102 Section 1A) and has no audit exemptions concerns, indicating good governance and financial reporting discipline.

---

4. Recommendations

1. Enhance Revenue Generation:
   Consider strategies to increase sales or diversify income streams to move beyond the current steady but limited scale. This may include marketing initiatives or expanding service offerings within the healthcare activities sector.

2. Monitor and Manage Cash Flow:
   Maintain the strong liquidity position but plan for working capital needs if growth occurs. Keeping a buffer ("healthy cash flow") is essential to avoid liquidity crunches during expansion phases.

3. Build a Debtors Ledger:
   If appropriate to the business model, offering credit terms to customers can stimulate sales growth. However, closely monitor receivables to avoid potential bad debt risks.

4. Explore Investment or Financing Options:
   With solid equity and no debt, the company is in a good position to consider external funding if growth opportunities arise, balancing leverage with maintaining solvency.

5. Continue Compliance and Reporting:
   Maintain timely filings and adherence to accounting standards to avoid penalties and preserve stakeholder confidence.

---